0001062993-22-020170.txt : 20221003 0001062993-22-020170.hdr.sgml : 20221003 20221003171925 ACCESSION NUMBER: 0001062993-22-020170 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221003 DATE AS OF CHANGE: 20221003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dentzer James E CENTRAL INDEX KEY: 0001400977 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15911 FILM NUMBER: 221288615 MAIL ADDRESS: STREET 1: C/O AMICUS THERAPEUTICS, INC. STREET 2: 6 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Imunon, Inc. CENTRAL INDEX KEY: 0000749647 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521256615 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 997 LENOX DRIVE STREET 2: SUITE 100 CITY: LAWRENCEVILLE STATE: NJ ZIP: 08648 BUSINESS PHONE: (609) 896-9100 MAIL ADDRESS: STREET 1: 997 LENOX DRIVE STREET 2: SUITE 100 CITY: LAWRENCEVILLE STATE: NJ ZIP: 08648 FORMER COMPANY: FORMER CONFORMED NAME: Celsion CORP DATE OF NAME CHANGE: 20071121 FORMER COMPANY: FORMER CONFORMED NAME: CELSION CORP DATE OF NAME CHANGE: 19980515 FORMER COMPANY: FORMER CONFORMED NAME: CHEUNG LABORATORIES INC DATE OF NAME CHANGE: 19920703 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2022-09-30 0000749647 Imunon, Inc. IMNN 0001400977 Dentzer James E C/O IMUNON, INC. 997 LENOX DRIVE, SUITE 100 LAWRENCEVILLE NJ 08648 1 0 0 0 Option (right to buy) 1.68 2022-09-30 4 A 0 2667 0 A 2032-09-30 Common Stock 2667 2667 D Represents an option grant under the Issuer's 2018 Stock Plan. The option vests in equal installments commencing January 1, 2023 and annually thereafter. /s/ James Dentzer by Jeffrey Church, Attorney-in-fact 2022-10-03